MediPharm Labs Corp.

A Trusted Global Leader in Purified Cannabis Concentrates

This website contains information about cannabis.
Please enter your birthday to confirm that you are of the legal age to consume cannabis in your province.


INVESTORS
  • MediPharm Labs Corp. on Twitter
  • MediPharm Labs Corp. on Facebook
  • MediPharm Labs Corp. on Instagram
  • MediPharm Labs Corp. on LinkedIn
  • MediPharm Labs Corp. on YouTube
  • About Us
    • Our Pharma Quality Standards
    • About Us
    • Management Team
    • Board of Directors
    • Science Advisory Committee
    • Strategic Alliances
    • Science of Extraction
    • COVID-19
    • Virtual Tour
  • Products & Services
    • White Label Production
    • Bulk Wholesale Offerings
    • MediPharm Brand
    • LABS Cannabis
    • Wayfarer
  • News
    • Press Releases
    • Blog
    • Events
    • In The News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • Financial Results
    • SEDAR
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
    • Customer Service
  • Australia
  • Search  
MediPharm Labs Corp. A Global Leader in Pharma-Quality, Cannabinoid-Based Products

MediPharm Labs Press Releases

News

News

  • Press Releases
  • Blog
  • Events
  • In The News

MediPharm Labs Announces Participation at Upcoming Conferences

May 29, 2020

MediPharm Labs and Argentia Gold to Bring Premium Cannabis-Infused Products to Atlantic Canada

May 27, 2020

MediPharm Labs and Ace Valley Deliver Innovative Vapes - Now Available in Several Markets Across Canada

May 25, 2020

MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos

May 15, 2020

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

May 14, 2020

MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

May 14, 2020

MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

May 7, 2020

MediPharm Labs Australia Signs its Second GMP White-Label Deal to Supply New Zealand’s Medical Cannabis Market

May 4, 2020

MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

Apr 24, 2020

MediPharm Labs to Present at KCSA Virtual Investor Conference

Apr 16, 2020
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...16
    Next Page
    © 2021 MediPharm Labs Corp. All Rights Reserved. MediPharm Labs Corp.
    151 John St.
    Barrie, ON L4N 2L1
    Canada
    +1 705 719 7425
    Privacy Policy Careers Disclaimer Terms and Conditions Sitemap